{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T12:31:19Z","timestamp":1774528279940,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2015,4,8]],"date-time":"2015-04-08T00:00:00Z","timestamp":1428451200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1007\/s10067-015-2929-7","type":"journal-article","created":{"date-parts":[[2015,4,7]],"date-time":"2015-04-07T02:56:20Z","timestamp":1428375380000},"page":"921-927","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Drug survival and causes of discontinuation of the first anti-TNF in ankylosing spondylitis compared with rheumatoid arthritis: analysis from BIOBADABRASIL"],"prefix":"10.1007","volume":"34","author":[{"name":"On behalf of BIOBADABRASIL","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B\u00e1rbara P.","family":"Faf\u00e1","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulo","family":"Louzada-Junior","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David C.","family":"Titton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliana","family":"Zandonade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Ranza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ieda","family":"Laurindo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Pe\u00e7anha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aline","family":"Ranzolin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9 L.","family":"Hayata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"In\u00eas G.","family":"Silveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Izaias","family":"Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 C.","family":"Macieira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luiz S.","family":"Guedes-Barbosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manoel B.","family":"Bertolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria F\u00e1tima Lobato da C.","family":"Sauma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00edlia B. G.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marlene","family":"Freire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morton A.","family":"Scheinberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vander","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Washington","family":"Bianchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 R. S.","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geraldo R. C.","family":"Pinheiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hellen M. S.","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claiton Viegas","family":"Brenol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivanio A.","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gl\u00e1ucio Ricardo Werner","family":"de Castro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00falio C. Bertacini","family":"de Morais","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheila K. F.","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirhelen Mendes","family":"de Abreu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto A.","family":"Toledo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcelo M.","family":"Pinheiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walber Pinto","family":"Vieira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Val\u00e9ria","family":"Valim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,4,8]]},"reference":[{"issue":"13","key":"2929_CR1","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1517\/14656566.8.13.2089","volume":"8","author":"E Toussirot","year":"2007","unstructured":"Toussirot E, Wendling D (2007) The use of TNF-alpha blocking agents in rheumatoid arthritis: an update. Expert Opin Pharmacother 8(13):2089\u2013107","journal-title":"Expert Opin Pharmacother"},{"issue":"6","key":"2929_CR2","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.3899\/jrheum.111125","volume":"39","author":"F Iannone","year":"2012","unstructured":"Iannone F, Gremese E, Atzeni F, Biasi D, Botsios C, Cipriani P, Ferri C, Foschi V, Galeazzi M, Gerli R, Giardina A, Marchesoni A, Salaffi F, Ziglioli T, Lapadula G, Gruppo Italiano di Studio sulle Early Arthritides (GISEA) (2012) Longterm retention of tumor necrosis factor-\u03b1 inhibitor therapy in a large italian cohort of patients with rheumatoid arthritis from the GISEA registry: an appraisal of predictors. J Rheumatol 39(6):1179\u201384","journal-title":"J Rheumatol"},{"issue":"3","key":"2929_CR3","doi-asserted-by":"crossref","first-page":"R72","DOI":"10.1186\/ar1941","volume":"8","author":"L Carmona","year":"2006","unstructured":"Carmona L, G\u00f3mez-Reino JJ, BIOBADASER Group (2006) Survival of TNF antagonists in spondylarthritis is better than in rheumatoid arthritis. Data from the Spanish registry BIOBADASER. Arthritis Res Ther 8(3):R72","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"2929_CR4","doi-asserted-by":"crossref","first-page":"719","DOI":"10.2147\/PPA.S47453","volume":"29","author":"V Mart\u00ednez-Santana","year":"2013","unstructured":"Mart\u00ednez-Santana V, Gonz\u00e1lez-Sarmiento E, Calleja-Hern\u00e1ndez M, S\u00e1nchez-S\u00e1nchez T (2013) Comparison of drug survival rates for tumor necrosis factor antagonists in rheumatoid arthritis. Patient Prefer Adherence 29(7):719\u201327","journal-title":"Patient Prefer Adherence"},{"issue":"6","key":"2929_CR5","first-page":"857","volume":"31","author":"CA Scir\u00e8","year":"2013","unstructured":"Scir\u00e8 CA, Caporali R, Sarzi-Puttini P, Frediani B, Di Franco M, Tincani A, Sinigaglia L, Sfriso P, Tirri R, Bellis E, Delsante G, Porru G, Salaffi F, Giuggioli D, Rossini M, Todoerti M, Bazzichi L, Govoni M, Gerli R, Raschetti R, Minisola G, Montecucco C, Todesco S (2013) Drug survival of the first course of anti-TNF agents in patients with rheumatoid arthritis and seronegative spondyloarthritis: analysis from the MonitorNet Database. Clin Exp Rheumatol 31(6):857\u201363","journal-title":"Clin Exp Rheumatol"},{"issue":"Suppl 2","key":"2929_CR6","doi-asserted-by":"crossref","first-page":"ii30","DOI":"10.1136\/ard.62.suppl_2.ii30","volume":"62","author":"M Flendrie","year":"2003","unstructured":"Flendrie M, Creemers MC, Welsing PM, den Broeder AA, van Riel PL (2003) Survival during treatment with tumour necrosis factor blocking agents in rheumatoid arthritis. Ann Rheum Dis 62(Suppl 2):ii30\u20133","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"2929_CR7","first-page":"1737","volume":"35","author":"SK Agarwal","year":"2008","unstructured":"Agarwal SK, Glass RJ, Shadick NA, Coblyn JS, Anderson RJ, Maher NE, Weinblatt ME, Solomon DH (2008) Predictors of discontinuation of tumor necrosis factor inhibitors in patients with rheumatoid arthritis. J Rheumatol 35(9):1737\u201344","journal-title":"J Rheumatol"},{"issue":"1","key":"2929_CR8","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/art.27227","volume":"62","author":"ML Hetland","year":"2010","unstructured":"Hetland ML, Christensen IJ, Tarp U, Dreyer L, Hansen A, Hansen IT, Kollerup G, Linde L, Lindegaard HM, Poulsen UE, Schlemmer A, Jensen DV, Jensen S, Hostenkamp G, \u00d8stergaard M (2010) Direct Comparison of Treatment Responses, Remission Rates, and Drug Adherence in Patients With Rheumatoid Arthritis Treated With Adalimumab, Etanercept, or Infliximab. Results From Eight Years of Surveillance of Clinical Practice in the Nationwide Danish DANBIO Registry. Arthritis Rheum 62(1):22\u201332","journal-title":"Arthritis Rheum"},{"issue":"7","key":"2929_CR9","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1136\/annrheumdis-2012-201933","volume":"72","author":"B Glintborg","year":"2013","unstructured":"Glintborg B, Ostergaard M, Krogh NS, Tarp U, Manilo N, Loft AG, Hansen A, Schlemmer A, Fana V, Lindegaard HM, Nordin H, Rasmussen C, Ejstrup L, Jensen DV, Petersen PM, Hetland ML (2013) Clinical response, drug survival and predictors thereof in 432 ankylosing spondylitis patients after switching tumour necrosis factor \u03b1 inhibitor therapy: results from the Danish nationwide DANBIO registry. Ann Rheum Dis 72(7):1149\u201355","journal-title":"Ann Rheum Dis"},{"key":"2929_CR10","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1136\/ard.2010.131797","volume":"1","author":"E Lie","year":"2011","unstructured":"Lie E, van der Heijde D, Uhlig T, Mikkelsen K, R\u00f8devand E, Koldingsnes W, Kaufmann C, Kvien TK (2011) Effectiveness of switching between TNF inhibitors in ankylosing spondylitis: data from the NOR-DMARD register. Ann Rheum Dis 1:157\u201363","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"2929_CR11","first-page":"958","volume":"27","author":"K Pavelka","year":"2009","unstructured":"Pavelka K, Forejtov\u00e1 S, Stolfa J, Chroust K, Buresov\u00e1 L, Mann H, Vencovsk\u00fd (2009) Anti-TNF therapy of ankylosing spondylitis in clinical practice. Results from the Czech national registry ATTRA. Clin Exp Rheumatol 27(6):958\u201363","journal-title":"Clin Exp Rheumatol"},{"key":"2929_CR12","unstructured":"Titton DC Comit\u00ea cient\u00edfico do BIOBADABRASIL (2009) BIOBADABRASIL: Registro Brasileiro de monitoriza\u00e7\u00e3o de terapias biol\u00f3gicas em doen\u00e7as reum\u00e1ticas \u2013 Protocolo vers\u00e3o 1.1. https:\/\/biobadaser.ser.es\/biobadamerica\/Brasil\/cgi-bin\/upload\/documentacion.aspx . Accessed 14 December 2014."},{"key":"2929_CR13","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/art.1780270401","volume":"27","author":"S Linden Van der","year":"1984","unstructured":"Van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361\u20138","journal-title":"Arthritis Rheum"},{"issue":"3","key":"2929_CR14","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31(3):315\u201324","journal-title":"Arthritis Rheum"},{"issue":"9","key":"2929_CR15","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD, Combe B, Costenbader KH, Dougados M, Emery P, Ferraccioli G, Hazes JM, Hobbs K, Huizinga TW, Kavanaugh A, Kay J, Kvien TK, Laing T, Mease P, M\u00e9nard HA, Moreland LW, Naden RL, Pincus T, Smolen JS, Stanislawska-Biernat E, Symmons D, Tak PP, Upchurch KS, Vencovsk\u00fd J, Wolfe F, Hawker G (2010) Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Arthritis Rheum 62(9):2569\u201381","journal-title":"Arthritis Rheum"},{"issue":"2","key":"2929_CR16","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1590\/S0482-50042012000200002","volume":"52","author":"LM Mota da","year":"2012","unstructured":"da Mota LM, Cruz BA, Brenol CV, Pereira IA, Rezende-Fronza LS, Bertolo MB, de Freitas MV, da Silva NA, Louzada-J\u00fanior P, Giorgi RD, Lima RA, da Rocha Castelar Pinheiro G, Brazilian Society of Rheumatology (2012) Brazilian Society of Rheumatology Consensus for the treatment of rheumatoid arthritis. Rev Bras Reumatol 52(2):152\u201374","journal-title":"Rev Bras Reumatol"},{"issue":"3","key":"2929_CR17","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1590\/S0482-50042013000300003","volume":"53","author":"PD Sampaio-Barros","year":"2013","unstructured":"Sampaio-Barros PD, Keiserman M, Meirelles Ede S, Pinheiro Mde M, Ximenes AC, Azevedo VF, Bonfiglioli R, Carneiro S, Ranza R, Bernardo WM, Gon\u00e7alves CR (2013) Recommendations for the management and treatment of ankylosing spondylitis. Rev Bras Reumatol 53(3):242\u201357","journal-title":"Rev Bras Reumatol"},{"issue":"3","key":"2929_CR18","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1136\/annrheumdis-2011-200302","volume":"71","author":"JJ G\u00f3mez-Reino","year":"2012","unstructured":"G\u00f3mez-Reino JJ, Rodr\u00edguez-Lozano C, Campos-Fern\u00e1ndez C, Montoro M, Descalzo M\u00c1, Carmona L, BIOBADASER 2.0 Study Group (2012) Change in the discontinuation pattern of tumour necrosis factor antagonists in rheumatoid arthritis over 10 years: data from the Spanish registry BIOBADASER 2.0. Ann Rheum Dis 71(3):382\u20135","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"2929_CR19","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/BOR.0b013e32835257c5","volume":"24","author":"S Arends","year":"2012","unstructured":"Arends S, van der Veer E, Kallenberg CG, Brouwer E, Spoorenberg A (2012) Baseline predictors of response to TNF-\u03b1 blocking therapy in ankylosing spondylitis. Curr Opin Rheumatol 24(3):290\u20138","journal-title":"Curr Opin Rheumatol"},{"issue":"2","key":"2929_CR20","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/art.23333","volume":"59","author":"MS Heiberg","year":"2008","unstructured":"Heiberg MS, Koldingsnes W, Mikkelsen K, R\u00f8devand E, Kaufmann C, Mowinckel P, Kvien TK (2008) The comparative one-year performance of anti-tumor necrosis factor alpha drugs in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: results from a longitudinal, observational, multicenter study. Arthritis Rheum 59(2):234\u201340","journal-title":"Arthritis Rheum"},{"issue":"11","key":"2929_CR21","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1136\/ard.2009.124446","volume":"69","author":"B Glintborg","year":"2010","unstructured":"Glintborg B, Ostergaard M, Krogh NS, Dreyer L, Kristensen HL, Hetland ML (2010) Predictors of treatment response and drug continuation in 842 patients with ankylosing spondylitis treated with anti-tumour necrosis factor: results from 8 years' surveillance in the Danish nationwide DANBIO registry. Ann Rheum Dis 69(11):2002\u20138","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"2929_CR22","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1093\/rheumatology\/ker281","volume":"50","author":"N Busquets","year":"2011","unstructured":"Busquets N, Tomero E, Descalzo M\u00c1, Ponce A, Ortiz-Santamar\u00eda V, Sur\u00eds X, Carmona L, G\u00f3mez-Reino JJ, BIOBADASER 2.0 Study Group (2011) Age at treatment predicts reason for discontinuation of TNF antagonists: data from the BIOBADASER 2.0 registry. Rheumatology (Oxford) 50(11):1999\u20132004","journal-title":"Rheumatology (Oxford)"},{"issue":"Suppl 1","key":"2929_CR23","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1186\/1478-6354-13-S1-S5","volume":"13","author":"PP Tak","year":"2011","unstructured":"Tak PP, Kalden JR (2011) Advances in rheumatology: new targeted therapeutics. Arthritis Res Ther 13(Suppl 1):S5","journal-title":"Arthritis Res Ther"},{"key":"2929_CR24","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.pathophys.2005.07.007","volume":"12","author":"S Chaiamnuay","year":"2005","unstructured":"Chaiamnuay S, Bridges SL Jr (2005) The role of B cells and autoantibodies in rheumatoid arthritis. Pathophysiology 12:203\u2013216","journal-title":"Pathophysiology"},{"issue":"1\u20132","key":"2929_CR25","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2152\/jmi.60.77","volume":"60","author":"S Yuasa","year":"2013","unstructured":"Yuasa S, Yamaguchi H, Nakanishi Y, Kawaminami S, Tabata R, Shimizu N, Kohno M, Shimizu T, Miyata J, Nakayama M, Kishi J, Toyoda Y, Nishioka Y, Tani K (2013) Treatment responses and their predictors in patients with rheumatoid arthritis treated with biological agents. J Med Invest 60(1\u20132):77\u201390","journal-title":"J Med Invest"},{"issue":"10","key":"2929_CR26","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1007\/s10067-013-2336-x","volume":"32","author":"CC Mok","year":"2013","unstructured":"Mok CC, van der Kleij D, Wolbink GJ (2013) Drug levels, anti-drug antibodies, and clinical efficacy of the anti-TNF\u03b1 biologics in rheumatic diseases. Clin Rheumatol 32(10):1429\u201335","journal-title":"Clin Rheumatol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-015-2929-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-015-2929-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-015-2929-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T23:23:25Z","timestamp":1747869805000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-015-2929-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,8]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["2929"],"URL":"https:\/\/doi.org\/10.1007\/s10067-015-2929-7","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,8]]}}}